3P BIOPHARMACEUTICALS Trademark

Trademark Overview


On Friday, February 15, 2019, a trademark application was filed for 3P BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the 3P BIOPHARMACEUTICALS trademark a serial number of 88303631. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, December 19, 2022. This trademark is owned by 3P BIOPHARMACEUTICALS, S.L.. The 3P BIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for medical purposes, namely, monoclonal antibodies for use in vaccines, therapy, diagnosis and research, biotechnological origin antibodies for use in therapy, diagnosis and research, antibody fragments for use in therapy, diagnosis and research, fused antibody fragments for use in therapy, diagnosis and research, conjugated antibodies for use in therapy, diagnosis and research, engineered antibodies for use in therapy, diagnosis and research, vaccines and natural biomaterials for augmentation of bone and tissue, biotechnological scaffolds for cell therapy products and controlled released drugs, synthetic protein scaffolds, engineered antibodies scaffolds, non-antibody binding proteins for pharmaceutical and industrial applications, proteins for pharmaceuticals and industrial applications
3p biopharmaceuticals

General Information


Serial Number88303631
Word Mark3P BIOPHARMACEUTICALS
Filing DateFriday, February 15, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, December 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements


Description of MarkThe mark consists of the wording "3P" with "3" in pink and the "P" in fuchsia. To the left is a fuchsia curved line design forming a "3" superimposed over the letter "P", with the word "BIOPHARMACEUTICALS" in fuchsia in vertical form to the left of the design.
Goods and ServicesBiopharmaceutical preparations for medical purposes, namely, monoclonal antibodies for use in vaccines, therapy, diagnosis and research, biotechnological origin antibodies for use in therapy, diagnosis and research, antibody fragments for use in therapy, diagnosis and research, fused antibody fragments for use in therapy, diagnosis and research, conjugated antibodies for use in therapy, diagnosis and research, engineered antibodies for use in therapy, diagnosis and research, vaccines and natural biomaterials for augmentation of bone and tissue, biotechnological scaffolds for cell therapy products and controlled released drugs, synthetic protein scaffolds, engineered antibodies scaffolds, non-antibody binding proteins for pharmaceutical and industrial applications, proteins for pharmaceuticals and industrial applications
Pseudo MarkTHREE P BIO PHARMACEUTICALS
Indication of Colors claimedThe color(s) fuchsia and pink is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 8, 2019
Primary Code005
First Use Anywhere DateSunday, December 31, 2006
First Use In Commerce DateThursday, February 28, 2019

Trademark Owner History


Party Name3P BIOPHARMACEUTICALS, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNOAIN (NAVARRA) 31110
ES

Party Name3P BIOPHARMACEUTICALS, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNOAIN (NAVARRA) 31110
ES

Trademark Events


Event DateEvent Description
Monday, December 19, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, December 19, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, December 19, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 7, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 7, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, May 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NON-FINAL ACTION E-MAILED
Monday, November 8, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, October 12, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 28, 2021USE AMENDMENT FILED
Tuesday, October 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 28, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 29, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, December 29, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, July 9, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 9, 2020FINAL REFUSAL E-MAILED
Thursday, July 9, 2020FINAL REFUSAL WRITTEN
Saturday, June 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 11, 2020ASSIGNED TO LIE
Thursday, June 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 4, 2019NON-FINAL ACTION E-MAILED
Wednesday, December 4, 2019NON-FINAL ACTION WRITTEN
Thursday, November 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2019NON-FINAL ACTION WRITTEN
Saturday, April 27, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 19, 2019NEW APPLICATION ENTERED